The University of Chicago Header Logo

Connection

Olatoyosi Odenike to Organ Size

Back to Details
This is a "connection" page, showing publications Olatoyosi Odenike has written about Organ Size.
Olatoyosi Odenike
Connection Strength
0.033
Organ Size
  1. Phase 1/2 study of pacritinib, a next generation JAK2/FLT3 inhibitor, in myelofibrosis or other myeloid malignancies. J Hematol Oncol. 2016 12 08; 9(1):137.
    View in: PubMed
    Score: 0.033
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.